PRICE HISTORY.
Use the left and right arrow keys to inspect dated observations. Home selects the first observation and End selects the latest.
Key numbers
Published fundamentals and the date each figure was recorded.
S3V Vascular Technologies Limited is an unlisted Indian medical-device company focused on the cardiovascular market and research and development in medical applications. Its FY2023-24 annual report describes three manufacturing plants in Mysuru: Plant No. 1 at Hootagalli for manufacturing and administration, Plant No. 2 at Hebbal, and Plant No. 3 at Hootagalli. The report says the company is developing critical electronic-based medical catheters such as FFR and IVUS products. Its financial notes identify revenue from operations and say sales are recognised when significant risks and rewards of ownership pass to customers, generally on dispatch. The accounts also show dedicated product-development-cost projects including BIPP, micro catheter, stent coating, bio-observable stent, integration of hypotube, neuro and spinal cage projects. The issuer’s report presents these activities as its device-development, manufacturing and commercial-sales operations.
About this company
S3V Vascular Technologies Limited is an Indian medical device company that develops and manufactures advanced cardiovascular and critical-care products. Incorporated in 2011 and headquartered in Mysore, Karnataka, the company operates a fully integrated model that combines in-house research and development, proprietary engineering, and regulated manufacturing facilities. This vertical integration allows S3V to design, build, and validate its devices domestically rather than relying on imported components, which has historically been a hallmark of the Indian interventional cardiology market. The company's product portfolio spans drug-eluting stents, bare-metal stents, self-expanding stents, PTCA and neurovascular catheters, balloon dilatation catheter systems, aspiration catheters, and esophageal and biliary stents. Flagship lines include the 3V-KROME cobalt-chromium coronary stent system and the 3V-PAULO balloon dilatation catheter, both of which have carried CE approval. S3V has also pursued frontier products such as an indigenous mechanical thrombectomy device for stroke treatment, a bioabsorbable drug-coated stent, and a balloon-expandable transcatheter aortic valve replacement (TAVR) system, positioning itself across coronary, peripheral, neurovascular, and structural-heart segments. S3V traces its origins to a group of founders from the Indian School of Business, and its promoter team includes engineers with long backgrounds in indigenous cardiac stent development in India. The company has raised capital across multiple funding rounds from a broad investor base to support its research pipeline and manufacturing expansion. In the unlisted market, S3V Vascular Technologies draws attention as a domestic medical-technology manufacturer operating in a sector with high regulatory barriers and import-substitution relevance. Interest is also linked to its reported intent to pursue a public listing, which places it among pre-IPO names that market participants track. Its shares are held privately and quoted on an over-the-counter, indicative basis, with prices varying across counterparties based on supply and demand. As with all unlisted securities, liquidity is limited and valuations are subject to negotiation and change.
COMPANY REGISTRY · ON FILE
THE CREW · BOARD & MANAGEMENT
COMMON QUESTIONS.
Is S3V Vascular Technologies Limited listed on the stock exchange?+
No. As of 2 September 2026, S3V Vascular Technologies Limited is an unlisted company whose shares trade over-the-counter; it would list only if and when it completes an IPO.
What is the S3V Vascular Technologies Limited unlisted share price?+
As of 2 September 2026, the indicative unlisted share price of S3V Vascular Technologies Limited is ₹545 per share. This is an over-the-counter reference price, not a stock-exchange quote.
What indicative minimum amount is displayed for S3V Vascular Technologies Limited unlisted shares?+
The displayed unit count is 20 share(s); at the indicative price of about ₹545, the displayed amount is approximately ₹10,900. This is a display convention, not evidence of inventory, an order minimum or a quote.
What is the ISIN of S3V Vascular Technologies Limited?+
The recorded ISIN of S3V Vascular Technologies Limited is INE0HGT01012. An ISIN is a 12-character security identifier. Verify it against the issuer and the relevant depository record before using it for any transfer or documentation.
Is trading in S3V Vascular Technologies Limited unlisted shares legal in India?+
Unlisted shares can be transferred off-market in India, but the legal, tax and compliance position depends on the security, parties, documents and current rules. Verify the intermediary, issuer restrictions and applicable requirements before proceeding.
Is there a lock-in period for unlisted shares?+
A post-listing lock-in may apply under the rules in force at the time. The period and any exemptions can depend on the holder and acquisition, so check the current regulation and the issuer's offer documents rather than relying on a generic period.
Do you guarantee returns?+
No. Unlisted shares carry higher risk and lower liquidity than listed shares. Returns depend on company performance, market conditions and future listing outcomes. This is information only, not investment advice.